Elevance Health (ELV) Change in Accured Expenses (2010 - 2026)

Elevance Health (ELV) has 17 years of Change in Accured Expenses data on file, last reported at $1.2 billion in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 67.75% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 53.31% increase from a year earlier, with the FY2025 full-year figure at -$720.0 million, down 164.71% from the prior year.
• Change in Accured Expenses for Q2 2026 stood at $1.2 billion, down from $2.9 billion in the prior quarter.
• Over the last five years, Change in Accured Expenses for ELV reached as high as $2.9 billion in Q1 2026 and fell as low as -$2.3 billion in Q4 2025.
• Historically, Change in Accured Expenses has averaged $310.9 million across 5 years, with a median of $215.0 million in 2022.
• Across the five-year window, Change in Accured Expenses soared 4679.41% in 2023 and plunged 1527.78% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at $226.0 million in 2022, then plunged by 134.07% to -$77.0 million in 2023, then plunged by 1458.44% to -$1.2 billion in 2024, then plunged by 88.25% to -$2.3 billion in 2025, then surged by 154.8% to $1.2 billion in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $1.2 billion in Q2 2026, $2.9 billion in Q1 2026, and -$2.3 billion in Q4 2025.